EDGE
Get a demo
Log In

apoQlar

Extended Reality
Product stageSegments
Seed
?
AR/VR platforms
?

German MedTech company apoQlar is the developer of the FDA Class II cleared VSI HoloMedicine medical mixed reality software platform. The company utilizes AI neural networks, computer vision and 3D rendering tech to convert grayscale medical images into color-based 3D objects, viewable through the Microsoft HoloLens 2 headset. Use cases include surgical planning, remote medical consultations and proctoring. The platform also allows for anatomy visualizations for learning purposes, being integrated with Microsoft Teams for streamlined communication across the classroom.

The company is also backed by a medical board consisting of over 35 medical advisors across 15+ medical fields

Key customers and partnerships

As of January 2024, the company had over 40 hospitals and 7 medical schools using its VSI HoloMedicine platform.

Funding and financials

In July 2023, apoQlar raised an undisclosed amount in a funding round led by YZR Capital, with funding used to facilitate the scaling of the VSI HoloMedicine version 2.0, expand the company’s market presence and scale globally.

Extended Reality

Extended Reality

Key stats
Featured companies
240
Total funding (USD)
13.6 Bn
Total addressable market (USD)
100.4 Bn
Key competitors
 
Loading...
Loading...
Loading...
Loading...
Product Overview
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Product Metrics
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Company profile
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...

Recent Updates

Partnerships
Product updates
Mar 12, 2024
apoQlar partners with Mayo Clinic to improve patient care utilizing XR
Extended Reality
Partnerships
Funding
Jul 5, 2023
Health tech company apoQlar secures undisclosed funding
Extended Reality
Product updates
Industry news
Dec 4, 2022
German-based apoQlar receives FDA clearance; launches first fundraising campaign
Extended Reality

Company Brief


HQ location:
Raboisen 32 C/O the-labs.space Hamburg DEU
Founded year:
2017
Employees:
51-100
Total Funding:
USD 10.8 million
Last Funding
USD 10.8 million, May 2024

Funding


Investors


No investor data is available

Funding data are powered by Crunchbase
arrow
menuarrow
Click here to learn more
Get a demo

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.